Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.02B | 9.37B | 9.16B | 8.48B | 8.03B |
Gross Profit | 3.35B | 3.51B | 3.54B | 3.13B | 2.86B |
EBITDA | 3.38B | 3.81B | 3.64B | 3.24B | 3.19B |
Net Income | 2.07B | 1.26B | 1.37B | 1.56B | 982.30M |
Balance Sheet | |||||
Total Assets | 66.69B | 60.65B | 56.85B | 53.57B | 52.24B |
Cash, Cash Equivalents and Short-Term Investments | 11.86B | 10.10B | 7.44B | 8.42B | 6.95B |
Total Debt | 48.90B | 44.24B | 42.22B | 38.86B | 42.70B |
Total Liabilities | 54.75B | 50.39B | 47.37B | 44.79B | 45.97B |
Stockholders Equity | 11.93B | 10.26B | 9.48B | 8.78B | 6.27B |
Cash Flow | |||||
Free Cash Flow | -5.08B | -1.91B | -3.65B | 2.09B | -969.36M |
Operating Cash Flow | 1.88B | 3.22B | 2.02B | 3.70B | 2.21B |
Investing Cash Flow | -4.24B | -2.02B | -5.66B | 656.52M | -3.13B |
Financing Cash Flow | 4.11B | 1.46B | 2.66B | -2.90B | 1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥9.96B | 5.18 | 4.87% | 13.64% | 128.96% | ||
76 Outperform | ¥7.84B | 12.71 | 2.60% | 38.82% | 35.82% | ||
75 Outperform | ¥8.67B | 4.30 | 1.73% | 6.93% | 63.17% | ||
72 Outperform | ¥9.55B | 10.39 | 5.46% | 11.64% | -30.52% | ||
68 Neutral | ¥9.68B | 27.06 | ― | 341.55% | -0.36% | ||
64 Neutral | €2.51B | 17.31 | 3.70% | 6.85% | 4.21% | 24.14% | |
52 Neutral | ¥6.53B | 114.71 | ― | 42.72% | -110.19% |